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Abstract
Prevention the development of malignant tumors and treatment of cancer patients remains an important problem today. In 
spite of substantive progress in the cancer diagnostics and treatment cancer occupies one of the main places in human morbidity 
and mortality in the World. Targeted therapy is an alternative to traditional one through targeted action on tumor cells and relatively 
low toxicity. Inhibitor of membrane tyrosine kinases dihydropyrrole derivative 5-amino-4-(1,3-benzothiazole-2-yl)-1-(3-methoxy-
phenyl)-1,2-dihydro-3Н-pyrrol-3-one (D-1) has significant antitumor activity on colorectal cancer and low toxicity acting in effective 
dose. However, to assess the D-1 therapeutic gap the investigation of its higher doses is necessary.
The investigation was aimed at D-1 effects applied at different doses compared to 5-fluorouracil one on rats ascending 
colon mucosa.
The research has found out that the dihydropyrrole derivative has no damaging effect on the colon of rats, whereas the admin-
istration of 5-fluorouracil causes marked mucosal lesion of the ascending colon. Hereby D-1 low toxicity to ascending colon mucosa 
compared to 5-FU and wide therapeutic gap of the first was concluded.
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1. Introduction 
In recent years there has been a fairly high level of digestive system cancer, which tends 
to increase. This remains a topical issue in modern medicine. Often one of the causes of cancer is 
impaired tyrosine kinase activation processes, which regulates the different stages of growth and 
proliferation of cells [1, 2]. Therefore, a promising trend in modern medicine is associated with 
targeted highly selective medicinal products, in particular membrane tyrosine kinase inhibitors 
characterized by high antitumor activity and lower toxicity as compared with traditional cytostat-
ics [3–6]. Medicinal products in this class include dihydropyrrole derivative 5-amino-4-(1,3-ben-
zothiazole-2-yl)-1-(3-methoxyphenyl)-1,2-dihydro-3Н-pyrrol-3-one (D-1) іn silico synthesized at 
Research and Production Biochemical Center of Taras Shevchenko National University as targeted 
inhibitors of protein kinase, which due to the spatial structure of the molecule interacts with the 
ATP-binding centre of tyrosine protein kinases and is their effective blocker [7–9]. Since the cyto-
toxic effect of the medicinal product D1 has been demonstrated on the transformed lines [7, 8, 10] 
and cancer cells [11], it is said to be a potential compound for use in clinical practice [12–14].
2. Aim of research
The aim of the research was to evaluate the effect of different doses of dihydropyrrole de-
rivative (D1) on the rectal mucosa of rats compared to the traditional chemotherapeutic agent 5-flu-
orouracil (5-FU).
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2. Materials and Methods 
2. 1. Experimental Animals
The studies were conducted on 90 white mongrel male rats with an average body weight of 
90±108 g. The rats were housed under standard environmental conditions (23±1 ºC, 55±5 % hu-
midity and a 12-h light: 12-h dark cycle) and maintained with free access to water and a standard 
laboratory diet ad libitum 
The study was conducted in accordance with the generally accepted bioethical standards of 
humane treatment of laboratory animals, in accordance with national and international regulations 
on carrying out experimental tests (“European Convention for the Protection of Vertebrate Animals 
used for experimental and other scientific purposes” (Strasbourg, 1986), “General Ethical Principles 
of Animal Experiments”, adopted by the First National Congress on Bioethics (Kiev, 2001).
2. 2. Grouping of experimental rats
The rats chosen for the study were divided in the eight groups and each group was experi-
mented as follows:
Group I: Rats of this group (control) were administrated oil containing 15 % DMSO (0.1 ml 
in total).
Group II: Rats of this group were administrated D1 at the dose of 2.3 mg/kg (conventionally 
effective) dissolved in sunflower oil containing 15 % DMSO (0.1 ml in total) per os, which, under 
the conditions of complete absorption, creates blood concentration of 10-4 M.
Group III: Rats of this group were administrated D1 at the dose of 11.5 mg/kg (5-fold the 
effective dose) dissolved in sunflower oil containing 15 % DMSO (0.1 ml in total) per os, which, 
under the conditions of complete absorption, creates blood concentration of 5×10-4 M.
Group IV: Rats of this group were administrated D1 at the dose of 23 mg/kg (10 times the 
effective dose) dissolved in sunflower oil containing 15 % DMSO (0.1 ml in total) per os, which, 
under the conditions of complete absorption, creates blood concentration of 10×10-4 M.
Group V: Rats of this group were administrated 5-FU at the dose of 0.86 mg/kg intraperi-
toneally, which, under the conditions of complete absorption, creates blood concentration 10-4  M.
Group VI: Rats of this group were administrated 5-FU at the dose of 4.3 mg/kg intra-
peritoneally, which, under the conditions of complete absorption, creates blood concentration 
5×10-4  M.
Group VII: Rats of this group were administrated 5-FU at the dose of 8.6 mg/kg (conven-
tionally effective) intraperitoneally, which, under the conditions of complete absorption, creates 
blood concentration 10×10-4  M.
Group VIII: Rats of this group were administrated 5-FU at the dose of 45 mg/kg (-fold the 
effective dose) intraperitoneally.
2. 3. Introduction of chemicals to rats
The effect of dihydropyrrole derivative (D1 (a new compound, the drug is not in his 
nature)) at different doses, and its comparison with 5-FU effect on the morphological and 
functional condition of the rat colon were studied in the setting of short exposure (14 days). 
The test substance was administered daily on an empty stomach. D1 at the doses of 2.3 mg/kg 
(conventionally effective), 11.5 mg/kg (5-fold the effective dose) and 23 mg/kg (10 times the 
effective dose) was injected dissolved in sunflower oil containing 15 % DMSO (0.1 ml in to-
tal) per os, which, under the conditions of complete absorption, creates blood concentration 
of 10-4 M, 5×10-4 M and 10×10-4 M respectively. 5-FU (VEROPHARM OJSC, solution for in-
travascular administration) was administered intraperitoneally at the doses of 0.86 mg/kg, 
4.3 mg/kg, 8.6 mg/kg (conventionally effective), which, under the conditions of complete ab-
sorption, creates blood concentration 10-4 M, 5×10-4 M, 10×10-4 M respectively, and 45 mg/kg 
(-fold the effective dose). Control animals received oil containing 15 % DMSO (0.1 mL in 
total). Animals were sacrificed 1 day after the last administration of the substances by CO2 
inhalation followed by cervical dislocation.
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2. 4. Tissue preparation
The histological examinations were performed using rectal segments, which were fixed in 
10 % neutral formalin saline, paraffin sections were prepared and stained with hematoxylin-eosin 
according to the standard procedure [15, 16]. The preparations were analyzed at the light-optical 
level using the microscope Bresser Researcher Trino (100, 400 magnification) (Bresser, Germany), 
coloured microphotographs were obtained using the digital camera Delta Optical CCD HDCE 5.0 
(Delta Optical, Poland) and the above mentioned microscope. The general condition of the rectal 
mucosa was evaluated, the relative amount of goblet cells and mitotic index of cells in the crypts 
were calculated. The morphometric study was conducted using WCIF ImageJ. The thickness of the 
mucosa, depth and width of crypts, height of colonocytes, sectional area of goblet cells and nuclei 
of colonocytes were measured.
2. 5. Statistical Analysis
The treatment of the experimental data was carried out by methods of variation statistics 
[16] using the software package SPSS 16.0: the data were tested for normality of distribution using 
the Kolmogorov-Smirnov Z-test, intergroup comparison was performed by one-way analysis of 
variance (ANOVA) with the use of posteriori multiple comparisons of Bonferroni test, and using 
U-Mann-Whitney test. The difference between the values of the parameters was compared, it was 
considered significant at p≤0.05.
3. Results 
Rectal mucosa of rats in the control group had a typical histological structure characteristic 
of this type of experimental animals, with no signs of pathological processes (Fig. 1, d). Morpho-
metric data are presented in Tables 1, 2.
Administration of 5-FU at the dose of 0.86 mg/kg resulted in lymph infiltration of the rec-
tal mucosa, oedema, isolated conglomerations of lymphoid tissue in the submucosa, sometimes 
distorted crypts (Fig. 1, a). Compared with the control group no probable changes were observed 
(Table 1, 2).
5-FU at a dose of 4.3 mg/kg caused lymph infiltration and oedema of the lamina propria 
(Fig. 1, b). Compared with the control group significantly increased the relative number of crypts 
bifurcation 77 % (Table 2), which is an indication of enhanced recovery.
Following the exposure to 5-FU at the dose of 8.6 mg/kg in the rectal mucosa there was dif-
fuse desquamation of the epithelial layer, lymph infiltration and oedema as well as dilation of blood 
capillaries and in the submucosa, sometimes proliferation of the lymphoid tissue (Fig. 1, c). The 
analysis of morphometric parameters showed significantly increased crypt depth by 24.7 % (which 
is an adaptive response), height of colonocytes by 42.6 % (which indicates certain strengthening of 
the functional activity of colonocytes), relative number of bifurcation crypts by 87.5 % (which is a 
sign of enhanced regeneration) (Table 1, 2). 
Table 1
Morphometric parameters of rectal mucosa of rats under the action of various doses of D1, 5-FU (M±SD)
Thickness of  
the mucosa, µm
Depth of  
crypts, µm
Width of  
crypts, µm
Height of  
colonocytes , µm
Square of  
colonocyte nuclei, µm2
Control 680.9±99.0 243.6±22.5 31.2±3.8 13.6±2.4 19.8±2.8
D1 2.3 mg/kg 710.9±99.0 250.7±85.2 30.4±8.4 15.6±7.4 17.6±9.3
D1 11.5 mg/kg 696.2±30.1 254.5±71.4 30.7±5.6 12.4±1.5 20.1±2.2
D1 23 mg/kg 925.3±107.3* 242.3±64.2 30.5±2.5 14.0±0.2 16.4±5.1
5-FU 0.86 mg/kg 694.2±182.7 268.4±50.7 29.7±10.1 10.4±1.3 16.6±1.1
5-FU 4.3 mg/kg 654.4±136.1 243.8±81.2 30.0±9.4 14.0±3.2 22.4±3.9
5-FU 8.6 mg/kg 800.7±109.7 303.9±16.8* 34.7±7.2 19.4±1.2* 23.4±5.4
Note: * – р≤0.05 vs. control
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Fig. 1. Photomicrography of the rat colon sections after exposure to 5-FU and D1 at various 
doses: a – 5-FU at the dose of 0.86 mg/kg, accumulation of leukocytes (inset ∆) and dense edema 
(arrowhead); b – 5-FU at the dose of 4.3 mg/kg, accumulation of leukocytes (inset ∆) and mid 
edema (arrowhead); c – 5-FU at the dose of 8.6 mg/kg, accumulation of leukocytes (inset ∆) and 
mid edema (arrowhead), diffuse desquamation of the epithelial ( ); d – control; e – D1 at the 
dose of 2.3 mg/kg; f – D1 at the dose of 11.5 mg/kg, accumulation of leukocytes (inset ∆);  
g – D1 at the dose of 23 mg/kg, accumulation of leukocytes (inset ∆), dense edema (arrowhead) 
and congestion of blood vessels ( ),×400, haematoxylin-eosin staining
Daily administration of 5-FU at the dose of 45 mg/kg (a weekly dose, 5-fold the effective 
dose) caused the death of the whole experimental group by the end of the first week of the experi-
ment. The animals experienced baldness, exhaustion, redness around the nose, inflammation of the 
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mucous membranes of the eyes, autopsy of the dead rats showed ulcers in the digestive tract and 
intestinal obstruction. 
The exposure to D1 at the effective dose (2.3 mg/kg) for 14 days caused no lesions of the rec-
tal mucosa, except dilation of blood capillaries (Fig. 1, e). Morphometric parameters of the mucosa 
did not differ significantly from the control (Table 1, 2).
In animals exposed D1 at the dose 5-fold of the effective dose (11.5 mg/kg) for 14 days there 
was lymph infiltration of the lamina propria, muscle layer thickening (Fig. 1, f ). In the serous layer 
there was noticeable vasodilatation and filling of vessels with blood. Morphometric parameters of 
the mucosa did not differ significantly from the control (Table 1, 2).
The exposure to D1 at the dose 10-fold of the effective dose of (23 mg/kg) for 14 days result-
ed in lymph infiltration of the lamina propria, oedema, sometimes vasodilatation, stasis of blood 
in the capillaries and minor bleeding (Fig. 1, g). Compared to the control there was an increase 
in the relative number of goblet cells by 35.8 % (Table 2), which is a sign of the increased mucus 
production in the mucosa. 
Table 2
Status of goblet cells and mitotic index of the rectum of rats exposed to various doses of D1, 5-FU (M±SD)
Goblet cell area, µm2 Relative number of  goblet cells,% Mitotic index, %
Relative number 
of bifurcation crypts, %
Control 77.9±44.4 23.8±4.6 5.8±1.1 4.8±0.8
D1 2.3 mg/kg 103.8±8.0 23.0±10.0 5.5±1.0 5.5±3.0
D1 11.5 mg/kg 90.4±5.5 25.5±5.0 6.0±4.0 4.0±1.0
D1 23 mg/kg 91.8±22.3 24.0±2.0 6.5±5.0 7.0±2.0
5-FU 0.86 mg/kg 108.5±76.7 22.5±1.0 7.5±1.0 4.5±3.0
5-FU 4.3 mg/kg 96.3±25.6 21.5±7.0 9.0±2.0 8.5±3.0*
5-FU 8.6 mg/kg 119.1±15.4 26.0±4.0 7.0±2.0 9.0±4.0*
Note: * – р≤0.05 vs. control
4. Discussion
Thus, the effects of both cytostatics in the rectal mucosa in rats are increased dose- 
dependently. 5-FU at the therapeutic dose did not lead to animal death (0.86, 4.3 and 8.6 mg/kg – ther-
apeutic), but caused desquamation of the epithelium, inflammation (as demonstrated by stroma oe-
dema, its lymph infiltration and hyperaemia as well as proliferation of the lymphoid tissue as a 
source of T and B lymphocytes). An increased functional activity of colonocytes and regenera-
tion are manifestations of adaptation processes. Such signs may indicate the development of drug 
acute catarrhal colitis [17].
5-FU at the doses below therapeutic efficacy has negative effects on the intestine. 5-FU at 
the dose 5-fold of the effective dose causes the death of animals with signs of exhaustion, ulcers 
of the gastrointestinal tract (GIT), constipation, hair loss. The reason for these phenomena is sup-
pression of the proliferation of the gastrointestinal epithelium (as a result – impaired digestion 
and absorption, slime excretion, motility) and skin – side effects characteristic of cytostatic action 
[4, 9]. Differing effects of various doses of 5-FU on the proliferation of progenitor cells of colono-
cytes and regeneration of mucosa can be explained by the different sensitivity of DNA and RNA 
synthesis to changes of the pool of nucleotides. RNA synthesis is more sensitive to the action of 
5-fluorouracil (direct incorporation of 5-FU in the RNA molecule instead of uracil) [2, 4, 6], and 
therefore cells differentiation “suffers”, which requires the expression of genes, and thus RNA 
synthesis. As a result, colonocytes in the crypts are immature and therefore, they age faster and are 
actively peeled requiring the active separation of predecessors to maintain the population of cells of 
the mucous membrane. DNA synthesis with replication is a more “protected”, possibly through an 
indirect effect of 5-FU (need for the synthesis of thymidine), and through multiple repair systems, 
so it is inhibited when exposed to higher (effective) dose of 5-FU [4, 18–20].
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D1, in contrast to 5-FU at the studied doses (relatively effective and higher) is low toxic to 
the colonic mucosa. So the signs of inflammation are observed during the exposure to the doses 
exceeding the effective 5 and 10 times. The proliferation of progenitor cells of colonocytes remains 
unaltered, intensity of the regenerating mucosa does not differ from physiological one. The findings 
indicate a fairly wide therapeutic window of D1, accordingly, its safety for the intestine, which is 
consistent with our previous data [11, 12, 14]. 
5. Conclusion 
1. Dihydropyrrole derivative 5-amino-4-(1,3-benzothiazole-2-yl)-1-(3-methoxyphenyl)-1,2-
dihydro-3Н-pyrrol-3-one (D-1), in contrast to 5-FU, is a low toxic compound for the colon of rats 
when exposed to the doses 5 and 10 times higher than conventionally effective.
2. The effect of D1 studied doses are limited to the signs of inflammation and mild desqua-
mation of the epithelium, in contrast to 5-FU, which leads to the development of drug colitis.
3. Proliferative activity of colonocyte progenitor cells and regeneration of the mucous mem-
brane under the action of all D1 studied doses remain at the physiological level.
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